Results 141 to 150 of about 119,738 (212)

Case Report: Dupilumab as a corticosteroid-sparing adjunct in severe mucocutaneous pemphigus vulgaris with prior avascular necrosis and chronic kidney disease. [PDF]

Front Med (Lausanne)
Hu Q, Yan Y, Liu F, Yu C, Liu L.
europepmc   +1 more source

BLyS/APRIL dual inhibition by telitacicept for refractory pemphigus vulgaris combined with hepatocellular cancer. [PDF]

An Bras Dermatol
Chen W, Xu J, Zhang Y.
europepmc   +1 more source

CD4+ T Cells Predict Relapse in Pemphigus Vulgaris Treated With Rituximab: A Retrospective Study. [PDF]

Oral Dis
Liguori S, Coppola N, Ruoppo E, Canfora F, Mignogna G, Mormile I, Fiore A, Castaldo G, Mignogna MD, Leuci S.   +9 more
europepmc   +1 more source

Rituximab resistant pemphigus vulgaris successfully treated with obinutuzumab. [PDF]

JAAD Case Rep
Hiel MAJ, Diercks GFH, Bolling MC, Bremer J, Meijer JM, Horváth B.   +5 more
europepmc   +1 more source

A case of juvenile pemphigus vulgaris effectively treated with dupilumab. [PDF]

JAAD Case Rep
Maruschak-Love S, Kost G, Mahmood MN, Sánchez-Espino LF.   +3 more
europepmc   +1 more source

Isolated perineal plaque as the initial presentation of pemphigus vulgaris. [PDF]

JAAD Case Rep
Workineh A, Panse G, Tomayko M, Little AJ.   +3 more
europepmc   +1 more source

Extensive cutaneous involvement in pemphigus vulgaris in a pediatric patient: a rare clinical image. [PDF]

Pan Afr Med J
Vihirkar S, Wankhede DK.
europepmc   +1 more source

Protocol for evaluating the effects of the intelligent multimodal symptom assessment and response system in patients with pemphigus vulgaris: a randomised controlled trial. [PDF]

BMJ Open
Chen Y, Wang L, Gao J, Xiao R, Yan S, Pan X, Yu Y, Yuan C, Yuan Y.   +8 more
europepmc   +1 more source

Pemphigus Vulgaris With an Elevated Faecal Calprotectin Mimicking Inflammatory Bowel Disease: A Case Report. [PDF]

Cureus
Abdullah A, Bertfield D, Chan C.
europepmc   +1 more source

CD19 CAR T-cell therapy is feasible for patients with pemphigus vulgaris treated without lymphodepletion in the RESET-PV trial.

Blood
Nunez D, Stadanlick J, Furmanak T, Goldenberg J, Choudhary GS, Ishikawa L, Werner M, Vorndran Z, Hadi-Nezhad F, Thompson D, Braccia D, Ellis A, Cicarelli J, Flanagan S, Williams J, Kobulsky D, Toreki A, Schreiber C, Bass N, Impagliazzo A, Lam Q, Dominguez A, Awan F, Zhou X, Brieva J, Abedi M, Maverakis E, Kresa-Reahl K, Tummala R, Chang D, Binder GK, Volkov J, Basu S.   +32 more
europepmc   +1 more source